The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 772K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

9 articles for M Renatus


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
11
Discovery of Ligands for TRIM58, a Novel Tissue-Selective E3 Ligase.EBI
Novartis Institutes for Biomedical Research
13
Discovery of New Binders for DCAF1, an Emerging Ligase Target in the Targeted Protein Degradation Field.EBI
Novartis Institutes for Biomedical Research
12
Optimization of the EBI
Novartis Pharma
27
Discovery of Potent, Highly Selective, and EBI
Novartis Institutes For Biomedical Research
23
Structure-Based Design and Preclinical Characterization of Selective and Orally Bioavailable Factor XIa Inhibitors: Demonstrating the Power of an Integrated S1 Protease Family Approach.EBI
Novartis Institutes For Biomedical Research
27
3-Amidinophenylalanine-based inhibitors of urokinase.EBI
UniversitäT Jena
25
Structural and functional analyses of benzamidine-based inhibitors in complex with trypsin: implications for the inhibition of factor Xa, tPA, and urokinase.EBI
Institut FüR Biochemie
21
N-aryl-piperidine-4-carboxamides as a novel class of potent inhibitors of MALT1 proteolytic activity.EBI
Novartis Institutes For Biomedical Research
1
Compounds useful as inhibitors of atr kinaseBDB
Vertex Pharmaceuticals